2026-171 CB Suministro de medicamentos para el tratamiento de la hipercolesterolemia primaria (familiar heterocigótica y no familiar) o displidemia mixta con inhibidores de PCSK9.
TED · 721574-2026Award noticeawardedNo deadline given
Value
Estimated€1,306,402 · 1,306,402.2 EUR
Awarded€1,306,402 · 1,306,402.2 EUR
WinnerAMGEN, S.A. | SANOFI-AVENTIS, S.A.
Who already wins at this buyer
Firms with recorded awards from CONSORCI HOSPITAL CLÍNIC DE BARCELONA (HCB) in this tender’s CPV categories — the incumbents you are bidding against.
Full buyer profile: what CONSORCI HOSPITAL CLÍNIC DE BARCELONA (HCB) buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Contrato basado en el Acuerdo marco del consorcio de salud y de atención social de Cataluña (Exp.:CSC F 3/21). Suministro de medicamentos para el tratamiento de la hipercolesterolemia primaria (familiar heterocigótica y no familiar) o displidemia mixta con inhibidores de PCSK9.
Similar tenders
Closest by meaning — across languages, via embeddings.